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Mucosal-associated invariant T (MAIT) cells are innate-like T cells that develop in the
thymus through three maturation stages to acquire effector function and differentiate
into MAIT1 (T-bet+) and MAIT17 (RORγt+) subsets. Upon activation, MAIT cells release
IFN-γ and IL-17, which modulate a broad spectrum of diseases. Recent studies indicate
defective MAIT cell development in microRNA deficient mice, however, few individual
miRNAs have been identified to regulate MAIT cells. MicroRNA-155 (miR-155) is a key
regulator of numerous cellular processes that affect some immune cell development,
but its role in MAIT cell development remains unclear. To address whether miR-155
is required for MAIT cell development, we performed gain-of-function and loss-of-
function studies. We first generated a CD4Cre.miR-155 knock-in mouse model, in
which miR-155 is over-expressed in the T cell lineage. We found that overexpression
of miR-155 significantly reduced numbers and frequencies of MAIT cells in all immune
organs and lungs and blocked thymic MAIT cell maturation through downregulating
PLZF expression. Strikingly, upregulated miR-155 promoted MAIT1 differentiation and
blocked MAIT17 differentiation, and timely inducible expression of miR-155 functionally
inhibited peripheral MAIT cells secreting IL-17. miR-155 overexpression also increased
CD4−CD8+ subset and decreased CD4−CD8− subset of MAIT cells. We further
analyzed MAIT cells in conventional miR-155 knockout mice and found that lack of
miR-155 also promoted MAIT1 differentiation and blocked MAIT17 differentiation but
without alteration of their overall frequency, maturation and function. Overall, our results
indicate that adequate miR-155 expression is required for normal MAIT1 and MAIT17
cell development and function.
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INTRODUCTION
Mucosal-associated invariant T (MAIT) cells are innate-like T lymphocytes that are involved in
antimicrobial immunity, acting as a bridge between the innate and adaptive immune responses.
Recently, MAIT cells have captured the attention of immunologists and clinicians because they
have been shown to be abundant in humans and affect a broad range of diseases, such as infectious
disease, autoimmune disease, and cancer (Duan et al., 2019; Godfrey et al., 2019; Legoux et al., 2020;
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Rodin et al., 2020). MAIT cells express a semi-invariant T cell
receptor (TCR) consisting of an invariant Vα chain (Vα19/Jα33
in mice and Vα7.2/Jα33 in humans) and a biased Vβ repertoire
(Reantragoon et al., 2013; Lepore et al., 2014). These TCRs give
MAIT cells the ability to recognize microbial riboflavin-derivative
antigens presented by MHC class I-related (MR1) molecules
(Kjer-Nielsen et al., 2012; Corbett et al., 2014; Legoux et al.,
2019). MAIT cells are detectable in a broad range of tissues, and
they are considerably more abundant in humans than in mice,
especially in non-mucosal tissues, where they represent up to
10% of blood T cells and 45% of liver T cells (Dusseaux et al.,
2011; Gherardin et al., 2018; Chen et al., 2019). In C57BL/6
mice, the highest frequency of MAIT cells in total αβT cells is
detected in the skin (5–40%), followed by lungs (3.3%), lamina
propria (0.7%), liver (0.6%), peripheral lymph nodes (0.2%),
blood (0.09%), spleen (0.08%), and thymus (0.05%) (Rahimpour
et al., 2015; Constantinides et al., 2019).
Mouse intra-thymic development of MAIT cells can be
divided into three developmental stages based on expression
of the surface markers CD24 and CD44 (Koay et al., 2016;
Wang and Hogquist, 2016). Interaction between double-positive
thymocytes expressing MR1 and those expressing TCRs generates
stage 1 (CD24+CD44−) committed precursors; these cells are
only found in the thymus and are the dominant subset in
very young (2–4 weeks) mice. Then, these cells cease CD24
expression, migrate to the medulla, and develop into stage 2
(CD24−CD44−) cells. The final maturation step is the emergence
of stage 3 (CD24−CD44+) cells that start to express classic
markers (IL-18R and PLZF) and more closely resemble mature
MAIT cells. Mature MAIT cells can be further divided into
MAIT1 (T-bet+) and MAIT17 (RORγt+) sub-lineages. MAIT1
cells mainly secrete IFN-γ and preferentially localize to the
liver and spleen, while MAIT17 cells produce IL-17 and are
positioned in mucosal tissues, such as lung, skin, and gut lamina
propria (Lantz and Legoux, 2019). Recently, Lee and colleagues
proposed the existence of MAIT2 cells (CD24−PLZFhi), which
mainly consist of stage 2 MAIT cells in the thymus, and these
cells were considered as developmental intermediates of MAIT1
and MAIT17 cells (Lee et al., 2020). Based on the expression
of CD4 and CD8, MAIT cells have four subsets, CD4+CD8−,
CD4−CD8+, CD4−CD8−, and CD4+CD8+, and their frequency
varies in a tissue- and strain-specific manner. Although the
majority of MAIT cells are CD4−CD8− in all tissues, a clear
population of MAIT cells express either CD4 or CD8 can be
observed in the thymus, spleen, lymph nodes, and liver in
C57BL/6 mice (Rahimpour et al., 2015; Constantinides et al.,
2019; Winter et al., 2019).
Upon stimulation, MAIT cells are rapidly activated and secrete
cytokines such as IFN-γ and IL-17, mediating functions that link
innate and acquired immunity in a broad spectrum of diseases,
including infection, cancer, allergy, and autoimmunity (Godfrey
et al., 2019). TCR-dependent and TCR-independent processes
involved in the activation of MAIT cells exert overlapping and
specific effector functions, and both activation pathways promote
a broad production of pro-inflammatory cytokines (Keller et al.,
2017; Godfrey et al., 2019; Hinks et al., 2019; Lamichhane et al.,
2019; Leng et al., 2019; Hinks and Zhang, 2020). The cytokine
and chemokine repertoire induced by MR1 ligand is dominated
by IL-17A, whereas a more modest cytokine response dominated
by IFN-γ is driven by IL-18 in synergy with IL-12 and IL-15 and is
potentiated by TL1A [Tumor necrosis factor (TNF)-like protein
1A; Leng et al., 2019]. Moreover, TCR-triggered MAIT cells show
specific enrichment of tissue repair functions (Hinks et al., 2019;
Lamichhane et al., 2019; Leng et al., 2019; Salou and Lantz, 2019).
In different species, strong similarities exist between human and
mouse MAIT cells in terms of tissue repair signatures and pro-
inflammatory cytokines and chemokines (Hinks et al., 2019; Leng
et al., 2019).
Increasing studies have reported that several genes regulate the
development and function of MAIT cells. Transcription factor
(PLZF) (Rahimpour et al., 2015; Koay et al., 2016), cytokines (IL-
1, IL-7, IL-12, IL-15, IL-18, IL-23) (Tang et al., 2013; Ussher et al.,
2014; Sattler et al., 2015; Constantinides et al., 2019; Berkson
et al., 2020), and other genes (MR1, CD1d, CCR7, CXCR6,
ZAP70, SAP, CXCR6, SATB1, Traj33, Jα18, DGKα, DGKζ) (Koay
et al., 2016, 2019a,b; Xie et al., 2019; Nejman et al., 2020)
are involved in the development and activation of MAIT cells.
Moreover, recent studies indicated that MAIT cell development
is controlled by the microRNAs (miRNAs) (Koay et al., 2016;
Koay and Godfrey, 2019; Winter and Krueger, 2019; Winter et al.,
2019). miRNAs, a class of 21–25 nucleotide single-stranded non-
coding small RNAs, are emerging as key regulators of numerous
cellular processes that affect cell development, homeostasis,
and disease development (Bartel, 2004). miRNAs repress their
target genes post-transcriptionally, and one individual miRNA
can potentially target multiple genes depending on the cellular
context. After complete deletion of miRNAs in T cells through
targeting Drosha (a member of the RNase III superfamily that
initiates the processing of miRNA), most MAIT cells are arrested
at stage 1 in the thymus, and failed to process to stage 2 and
stage 3, suggesting that miRNAs control MAIT cell development
beyond stage 1 (Koay et al., 2016). In miR-181a/b-1 (a pair of
microRNAs that serve as a rheostat of TCR signal strength)
deficient mice, frequency of MAIT cells is decreased in the
thymus and peripheral organs; most MAIT cells are profoundly
arrested at stage 1; functional maturation of MAIT cells is
precluded; PLZF expression is reduced and differentiation of
thymic MAIT cells is also affected (Winter et al., 2019).
miR-155 is highly expressed in monocytes/macrophages, B
cells, and T cells, and upregulation of miR-155 has been shown
to be a consistent feature of the mammalian inflammatory
response (Vigorito et al., 2007; Teng et al., 2008). Abundant
studies have reported the various roles of miR-155 in regulating
the differentiation and response of multiple immune cells,
including Th17 and regulatory T cells (Seddiki et al., 2014).
Furthermore, we and others have reported that miR-155 plays
an important role in invariant natural killer T (iNKT) cell
development and function (Burocchi et al., 2015; Frias et al.,
2018; Wang et al., 2021). However, the role of miR-155 in
MAIT cell development and functional lineage differentiation
remains unknown. To ascertain the potential role of miR-155
in MAIT cell development and function, two complementary
approaches, gain-of-function and loss-of-function, were used.
We first generated a CD4Cre.miR-155 knock-in (KI) mouse
Frontiers in Cell and Developmental Biology | www.frontiersin.org 2 April 2021 | Volume 9 | Article 670531
fcell-09-670531 April 2, 2021 Time: 17:21 # 3
Liu et al. MicroRNA-155 Regulates MAIT Cell Differentiation
model, in which miR-155 is specifically over-expressed in
the T cell lineage. We found that overexpression of miR-
155 significantly reduced number and frequencies of MAIT
cells in all lymphoid organs and lung, blocked thymic MAIT
cell maturation, and increased CD8+ subset and decreased
CD4−CD8− subset of MAIT cells. Strikingly, upregulated miR-
155 promoted MAIT1 differentiation and blocked MAIT17
differentiation, and inducible expression of miR-155 functionally
inhibited peripheral MAIT cells secreting IL-17. We further
analyzed MAIT cells in conventional miR-155 knockout mice and
found that lack of miR-155 also promoted MAIT1 differentiation
and blocked MAIT17 differentiation but without alteration of
their frequency, maturation and function. Our results uncover
miR-155 as a key epigenetic regulator for MAIT1 and MAIT17
cell development and function.
MATERIALS AND METHODS
Mice
Conventional miR-155 KO in the C57BL/6J background and
wild-type (WT) C57BL/6J mice were purchased from the
Jackson Laboratory (Bar Harbor, ME). Mice carrying the miR-
155KI.Rosa26.GFP allele (Jackson Laboratory) were bred with
CD4Cre transgenic mice (Jackson Laboratory) to obtain mice
expressing CD4Cre with one or two copies of the miR-155 KI
allele. Mice with two copies of the miR-155 KI allele, miR-155KI
mice (CD4Cre+miR-155KI, miR-155KI), and the WT littermate
CD4Cre−miR-155 KI mice served as controls. Inducible miR-155
overexpression mice were generated by crossing miR155KI-GFP
mice with ubiquitin C promoter-driven, tamoxifen-inducible Cre
(UbcCreER) transgenic mice (Jackson Laboratory). Experiments
were conducted on 8–15-week-old mice that matched for age
and gender. Mice were housed in a specific pathogen-free barrier
unit. Handling of mice and experimental procedures were in
accordance with requirements of the Institutional Animal Care
and Use Committee.
Cell Preparation
Single-cell suspensions of thymus, spleen, and lymph nodes
(LNs) were obtained by gently grinding each organ through
a 40 µm filter. Red blood cells in spleen were lysed using
red blood cell lysis buffer. For lymphocyte isolation from the
lung and liver, the two organs were immediately perfused with
phosphate-buffered saline (PBS) after mice were sacrificed. Lung
tissues were cut into pieces and treated in digestion solution
(PBS + 3%FBS + DNase [100 U/ml] + Collagenase D [1 mg/ml])
for 50 min at 37 ◦C on a shaker. Hepatic leukocytes were isolated
by density gradient centrifugation with 33% percoll medium
(50 ml 33% percoll: 1.84 10 × PBS + 16.56 ml percoll + 31.6 ml
RPMI medium) at 2,300 rpm at room temperature for 25 min
without acceleration or brake.
Flow Cytometry
Single-cell suspensions were washed with staining buffer (1X
PBS, 2% FBS) and incubated with Fc block (clone 2.4G2).
Cells were stained with MR1-tetramers (provided by the NIH
Tetramer Core Facility). The following conjugated mAbs were
used: TCRβ (H57–597), CD24 (30-F1), CD44 (IM7), PLZF
(9E12), RORγt (B2D), T-bet (eBio4B10), CD8 (53-6.7), CD4
(RM4-5), IFN-γ (XMG1.2), and IL-17a (eBio17B7). All mAbs
were purchased from eBioscience, Biolegend, or TONBO.
Cell surface staining was performed with staining buffer.
Intranuclear staining for PLZF, T-bet, and RORγt was performed
with eBioscience Fixation/permeabilization buffer. The flow
cytometry assay was performed through BD FACSCelesta and
data were analyzed using FlowJo V10.2 software. The gating
strategy was as follows: after gating on lymphocyte, doublets
were excluded by using forward scatter (FSC) and side scatter
(SSC), and MAIT cells were identified as TCRβ+ MR1-
tetramer+.
Tamoxifen Treatment
Tamoxifen (Sigma Aldrich, St. Louis, MO) was dissolved in corn
oil (Sigma Aldrich) containing 10% (vol/vol) ethanol (Thermo
Fisher Scientific) and was intraperitoneally administered at
50 mg/kg of mouse weight for five consecutive days.
In vitro Functional Assays
Single-cell suspensions from spleen, LNs, liver and lung were
cultured in T cell culture medium (RPMI 1640 with 10% FBS,
HEPES, penicillin and streptomycin, pyruvate, non-essential
amino acids, L-glutamine, and 2-ME) in the presence of phorbol
12-myristate 13-acetate (PMA) (50 ng/ml) and Ionomycin
(1 µM) for a total of 4 h at 37 ◦C. Brefeldin A was then
added in the last 2.5 h at a final concentration of 1 µM. Anti-
IFN-γ and anti-IL-17 were detected by intracellular staining
and flow cytometry.
MAIT Cell Enrichment
Total thymocytes were stained with APC-conjugated MR1
tetramer, bound to anti-APC MicroBeads (Miltenyi Biotec),
and enriched on an autoMACS Pro Separator (Miltenyi Biotec)
using the POSSEL_S program (Constantinides et al., 2019).
Positively selected cells were then stained with surface and
intracellular antibodies to examine the developmental stage and
functional linage.
Real-Time RT-PCR
RNA from thymic CD4+ T cells from miR-155 KI and WT
counterpart mice was purified by using the EXIQON isolation.
RNA was reverse transcribed using the PrimeScriptTM RT
reagent kit, and RT-qPCR was performed on an Applied
Biosystems 7900 Real-Time PCR. Expression levels of miR-
155 were normalized with snoRNU202, and fold change was
calculated using the 2−11CT method.
Statistical Significance
GraphPad Prism 8.0 was used for statistical analysis (unpaired,
two-tailed, t-test with a confidence interval of 95%). A p < 0.05
was considered statistically significant.
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RESULTS
Reduced Frequency and Number of
MAIT Cells in CD4Cre miR-155 KI Mice
To dissect the role of miR-155 on MAIT cell development, a
gain-of-function study was first performed using mice with T
cell-specific overexpression of miR-155. Mice carrying the miR-
155KI.Rosa26.GFP KI allele were bred with CD4Cre transgenic
mice to generate mice overexpressing the miR-155KI allele in
T cell linage (CD4Cre+miR-155KI, miR-155KI; Figure 1A).
Substantial upregulation of miR-155 was confirmed by RT-PCR
in sorted TCRβ+ T cells from thymus in miR-155 KI mice
(Figure 1B). Given that the T cells from miR-155 KI mice
were GFP positive, we therefore used flow cytometry to further
confirm the overexpression of miR-155. As expected, we found
that miR-155-GFP was indeed upregulated in T cells and MAIT
cells (Figure 1C).
The frequency and number of MAIT cells were measured in
the different immune and non-immune organs from miR-155 KI
and WT mice, including thymus, spleen, LNs, liver, and lungs
by flow cytometry, based on the surface staining of TCRβ and
5-OP-RU-MR1 tetramers. Due to the rareness of MAIT cells in
the thymus, we enriched MAIT cells from total thymocytes using
APC-conjugated MR1-tetramer. We found significant reduction
in the frequencies of thymic and peripheral MAIT cells in miR-
155 KI mice, with an approximately twofold reduction in all
organs (Figures 1D,E). As expected, a significant decrease in
the absolute number of MAIT cells was also detected in these
organs (Figure 1F). Thus, overexpression miR-155 impairs MAIT
cell development.
Overexpression of miR-155 Blocks
Thymic MAIT Cell Maturation
To precisely explore the effect of miR-155 on MAIT cell
maturation, cell surface markers distinguishing the MAIT cell
maturation stages were assessed in thymic and peripheral MAIT
cells. The frequencies of stage 1 (CD24+CD44−) and stage
2 (CD24−CD44−) MAIT cells were significantly increased in
the thymus, however, the frequency of stage 3 (CD24−CD44+)
MAIT cells were significantly reduced in miR-155 KI mice
compared to WT mice. However, the absolute numbers of stages
1, and 2 cells in miR-155KI mice were comparable with those in
WT mice, whereas stage 3 MAIT cells were dramatically reduced
in miR-155KI mice (Figures 2A,B). Interestingly, unlike MAIT
cells in thymus, the frequencies of mature MAIT cells were
comparable in spleen, LNs, liver and lung between miR-155 KI
mice and WT mice, but the absolute numbers were decreased
dramatically (Figure 2C).
A previous study has reported that ˜70% of thymic MAIT cells
express the transcription factor PLZF, similar to the frequency
of mature stage 3 MAIT cells (Winter et al., 2019). Given that
miR-155 affected thymic MAIT cell maturation, we therefore test
PLZF expression. Consistently, the expression of PLZF in thymic
MAIT cells was decreased dramatically in miR-155 KI mice
compared to WT mice (Figures 2D,E), suggesting that miR-155
may control thymic MAIT cell development at least through
targeting PLZF. However, the up-regulation of miR-155 did not
significantly alter PLZF expression in MAIT cells from peripheral
organs, which is consistent with the unaltered maturation of
peripheral MAIT cells in miR-155 KI mice compared to WT mice
(Figures 2D,F).
Overexpression of miR-155 Promotes
MAIT1 and Blocks MAIT17 Differentiation
Thymic MAIT cells at stage 3 are functionally mature cells that
have the potential to secrete cytokines and express the effector-
associated transcription factors PLZF, RORγt, and T-bet. Recent
studies showed that MAIT1 (T-bet+) cells preferentially localize
in the liver, while MAIT17 (RORγt+) cells are positioned in
mucosal tissues such as lung, skin, and gut lamina propria
(Lantz and Legoux, 2019; Salou et al., 2019). To evaluate the
potential role of overexpressing miR-155 in MAIT cell functional
lineage differentiation, MAIT cells from the thymus, spleen, LNs,
liver, and lung from miR-155 KI mice and WT littermates were
analyzed for MAIT1 and MAIT17 differentiation. We found that
the frequency of thymic MAIT17 cells was significantly reduced
and the frequency of MAIT1 cells was increased dramatically in
miR-155 KI mice (Figures 3A,B). Consistent with the thymic
phenotype, miR-155 KI mice exhibited a remarkably decreased
frequency of MAIT17 cells in peripheral organs, including spleen,
LNs, liver, and lung (Figures 3A,B). The frequency of peripheral
MAIT1 cells in miR-155 KI mice was significantly increased
in the spleen and LNs compared to WT mice (Figure 3B).
The absolute number of MAIT17 decreased dramatically, but
the number of MAIT1 cells was comparable in miR-155 KI
mice (Figure 3C). To characterize the function of MAIT cells,
the cells of liver and lungs from miR-155KI and WT mice
were stimulated with PMA/Ionomycin for 4 h in vitro. IL-
17 producing MAIT cells were significantly decreased in the
liver but not in the lung. We did not observe any significant
changes in IFN-γ-producing MAIT cells between KI and WT
mice, which was consistent with their differentiation phenotype
(Figure 3D). Thus, MAIT cells with miR-155 overexpression
showed interrupted MAIT cell differentiation, indicating an
essential role for miR-155 in MAIT1 and MAIT17 cell functional
lineage differentiation.
miR-155 Overexpression Increases CD8+
MAIT Subset but Decreases CD4−CD8−
MAIT Subset
Although antigen recognition by MAIT cells does not rely on
CD4 or CD8 coreceptors, MAIT cells do show heterogeneous
expression of CD4 and CD8, with 4 different MAIT cell subsets,
CD4+CD8−, CD4−CD8+, CD4−CD8−, and CD4+CD8+ in
the thymus, while 3 major subsets CD4+CD8−, CD4−CD8+,
CD4−CD8− MAIT cells in peripheral tissues. In thymus, CD4
is highly expressed on stage 1 and 2 MAIT cells but is rarely
expressed on most mature stage 3 MAIT cells. CD4+ stage 3
MAIT cells are likely to represent newly arrived stage 3 cells that
have not yet committed to either MAIT1 or MAIT17 cells with
functional maturation (Koay et al., 2019b). CD4−CD8− MAIT
cell subset is almost exclusively in barrier sites, including skin,
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FIGURE 1 | miR-155 overexpression interferes MAIT cell development. (A) CD4Cre miR-155 KI mouse model. (B) Thymic T cells were harvested from WT controls
and miR-155 KI mice. Total RNA was purified and miR-155 and snoRNU202 expression was measured by RT-PCR. (C) Histogram showing GFP expression of T
cells and MAIT cells in miR-155KI mice. (D) Defective MAIT cell development in miR-155 KI mice. Representative flow cytometric plots showing the frequencies of
MAIT cells in the thymus, spleen, LNs, liver, and lung of WT and miR-155 KI mice. Numbers adjacent to outlined areas indicate frequency of indicated populations.
(E) The percentage and (F) the absolute numbers of MAIT cells in indicated organs from miR-155 KI mice. Data are from at least three independent experiments.
Each mouse is represented as one dot. 3–8 mice for each group. Data were analyzed by unpaired t-test. *p < 0.05, **p < 0.01 compared to WT.
lung, and gut, suggesting that double negative MAIT cells at
barrier tissues may represent the most mature developmental
stage (Rahimpour et al., 2015; Constantinides et al., 2019;
Winter et al., 2019). Analysis of coreceptor expression on MAIT
cells in miR-155 KI and WT mice revealed that CD4+CD8− and
CD4+CD8+ subsets were almost equivalent (data not shown),
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FIGURE 2 | Role of miR-155 in MAIT cell maturation. (A) The developmental stages of thymic and peripheral MAIT cells were assessed by staining the surface
expression of CD24 and CD44 gated on MAIT cells. (B) Frequency and absolute number of enriched thymic MAIT cells at each stage of development and (C)
frequency and absolute number of CD44+ mature MAIT cells in peripheral organs. (D) Histograms showing PLZF expression by gated MAIT cells in indicated organs
of WT (black outline) and miR-155 KI (gray) mice. (E) Expression of PLZF in thymic and (F) peripheral MAIT cells. Data are from two independent experiments. Each
mouse is represented as one dot. 3–8 mice for each group. Data were analyzed by unpaired t-test. *p < 0.05 compared to WT.
but increased frequencies of CD4−CD8+ cells and reduced
frequencies of CD4−CD8− cells were observed in miR-155 over-
expressing MAIT cells from thymus, spleen, LNs, liver, and lung
(Figures 4A,B).
To ascertain whether the impairment of MAIT cell sub-
lineage differentiation in miR-155 KI mice is associated
with CD4 and CD8 coreceptor expression, we examined the
expression of CD4 and CD8 in MAIT17 and MAIT1 cells.
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FIGURE 3 | miR-155 overexpression regulates MAIT 1 and MAIT17 differentiation. (A) Expression of transcription factors in thymus and peripheral organs of MAIT
cells from WT and miR-155 KI mice examined by intracellular staining of RORγt and T-bet. MAIT17 cells are defined as RORγt+ T-bet− subsets and MAIT1 cells are
defined as RORγt− T-bet+ subsets. Numbers adjacent to outlined areas indicate percentage of indicated populations. (B) The percentage and (C) absolute number
of MAIT17 and MAIT1 cells in thymus and peripheral organs. (D) IL-17 and IFN-γ production of MAIT cells from liver and lung in miR-155 KI mice. Data are from at
least two independent experiments. Each mouse is represented as one dot. 3–8 mice for each group. Data were analyzed by unpaired t-test. *p < 0.05, **p < 0.01
compared to WT.
As shown in Figures 4C–F, the CD4−CD8− cell subset was
abundant in MAIT17 cells and the CD4−CD8+ cell subset
was enriched in MAIT1 cells in the thymus, spleen, LNs,
liver, and lung; whereas the decreased CD4−CD8− subset and
increased CD4−CD8+ subset were observed both in miR-155
over-expressing MAIT1 and MAIT17 cells from thymus and
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FIGURE 4 | miR-155 increases CD4−CD8+ subset and decreases CD4−CD8− subset in thymic and peripheral MAIT cells. (A) Flow cytometry analysis of CD4 and
CD8 coreceptor expression on MAIT cells from thymus, spleen, LNs, liver, and lung from WT and miR-155 KI mice. (B) Percentage of MAIT cell subsets that express
CD8, or neither coreceptor [CD4−CD8−] in the indicated organs. (C) Analysis of CD4 and CD8 expression on MAIT17 cells. (D) Percentages of CD4−CD8+ subset
and CD4−CD8− subset in MAIT17 cells. (E) CD4 and CD8 coreceptor expression pattern on MAIT1 cells in the indicated organs. (F) Percentages of CD4−CD8+
subset and CD4−CD8− subset in MAIT1 cells. Data are from at least three independent experiments. Each mouse is represented as one dot. 3–8 mice for each
group. Data were analyzed by unpaired t-test. *p < 0.05, **p < 0.01 compared to WT.
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FIGURE 5 | miR-155 is essential to the function of MAIT cells. (A) Histogram showing GFP expression of splenocytes in UBC− miR-155 KI mice and UBC+ miR-155
KI mice after tamoxifen treatment. (B) Cytokines (IL-17 and IFN-γ) production of MAIT cells from spleen and LNs in UBC miR-155 KI mice. Data are from two
independent experiments. Each mouse is represented as one dot. 3 mice for each group. Data were analyzed by unpaired t-test. **p < 0.01 compared to WT.
peripheral organs (Figures 4C–F). These data implied that the
alteration of CD4 and CD8 coreceptors may be involved in the
interruption of MAIT cell sub-lineage differentiation in miR-
155 KI mice.
Overexpression of miR-155 Inhibits MAIT
Cell Secreting IL-17
In order to bypass early developmental defects and delineate the
impact of miR-155 in MAIT cell function, we generated inducible
UBC+miR155KI-GFP mice by breeding miR155KI-GFP mice
with a mouse expressing tamoxifen-inducible Cre (UBC−Cre ER
mice). The UBC− miR155KI-GFP mice and UBC+ miR155KI-
GFP mice were treated with tamoxifen for 5 consecutive
days, flow cytometry was used to confirm the up-regulation
of miR-155 in splenocytes by GFP expression 9 days after
tamoxifen treatment (Figure 5A). Following PMA/Ionomycin
stimulation, we analyzed IL-17 and IFN-γ secreting MAIT cells,
and we found significant reduction of IL-17-secreting MAIT cells
from spleen, but IFN-γ-secreting MAIT cells were comparable
both in spleen and LNs between UBC− miR155KI-GFP mice
and UBC+ miR155KI-GFP mice (Figure 5B), indicating that
timely inducible expression of miR-155 inhibits function of
peripheral MAIT cells.
miR-155 Deficiency Does Not Affect
MAIT Cell Development but Interrupts
Thymic MAIT1 and MAIT17 Cell
Differentiation
To further dissect the role of miR-155 on MAIT cell development,
a loss-of-function study was performed using conventional miR-
155 knockout (KO) mice and age- and sex-matched WT mice.
The frequencies and absolute numbers of MAIT cells in thymus,
spleen, LNs, liver, and lung peripheral organs were comparable
between miR-155 KO and WT mice (Figures 6A–C). The
frequencies and absolute numbers of MAIT cells at different
mature stages in miR-155 KO were unaltered compared to
those in WT mice based on CD24 and CD44 expression
(Figures 6D–F).
Next, the effect of miR-155 deletion on functional lineage
differentiation was assessed both in thymus and peripheral
organs. In the thymus, MAIT17 subset was dramatically
decreased and MAIT1 was increased remarkably in miR-155
deficiency mice. However, no dramatic changes of MAIT1
and MAIT17 were observed in MAIT cells from peripheral
organs in miR-155 KO mice. For the RORγt−Tbet− subsets, no
significant difference was found both in thymus and periphery
(Figures 7A,B). Following PMA/Ionomycin stimulation, IL-17
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FIGURE 6 | miR-155 deletion results in unchanged MAIT cell development. (A) Flow cytometric plots showing the frequencies of MAIT cells in the thymus, spleen,
LNs, liver, and lung of WT and miR-155 KO mice. Numbers indicate percentage of cells within the drawn gate. Graph shows (B) the percentage and (C) absolute
numbers of MAIT cells in the indicated organs of miR-155 KO mice. (D) Flow cytometry plot indicating CD24 and CD44 expression gated on MAIT cells from thymus
and peripheral organs. (E) Percentage and absolute number of stage 1, stage 2 and stage 3 MAIT cells in enriched thymus. (F) Frequency and absolute number of
CD44+ mature MAIT cells in peripheral lymphocytes. Data are from at least three independent experiments. Each mouse is represented as one dot. 3 mice for each
group. Data were analyzed by unpaired t-test.
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and IFN-γ secretion were comparable in MAIT cells from liver
and lung between miR-155KO and WT mice (Figures 7C,D).
The frequencies of CD4+CD8−, CD4−CD8+, and CD4−CD8−
subsets in most organs were equivalent between miR-155KO and
WT mice, but a significant decrease of CD4+CD8− cells was
detected in LNs from miR-155KO mice (Figures 7E,F). Taken
FIGURE 7 | Differentiation and function of MAIT cells were unaffected substantially by the absence of miR-155. (A) Flow cytometric analysis of intracellular RORγt
and T-bet expression in MAIT cells from thymus, spleen, LNs, liver, and lung in WT and miR-155KO mice. Numbers adjacent to outlined areas indicate percentage of
indicated populations. (B) The percentages and absolute numbers of MAIT 17, MAIT1, RORγt−Tbet− subsets in thymus and peripheral organs. (C) IL-17 and IFN-γ
production of MAIT cells from liver and lung in miR-155 KO mice. (D) Percentage of IL-17 and IFN-γ in liver and lung. (E) Flow cytometry analysis of CD4 and CD8
coreceptor expression on MAIT cells in thymus, spleen, LNs, liver, and lung from WT and miR-155KO mice. (F) Percentage of MAIT cells subsets that express CD4,
CD8, or neither coreceptor in the indicated organs. Data are from at least three independent experiments. Each mouse is represented as one dot. 3–8 mice for each
group. Data were analyzed by unpaired t-test. *p < 0.05, **p < 0.01 compared with WT controls.
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together, deficiency of miR-155 promoted MAIT1 differentiation
and blocked MAIT17 differentiation but without alteration of
their overall frequency, maturation and function.
DISCUSSION
MAIT cells are a special lineage of T lymphocytes that go through
a distinct developmental pathway controlled by a unique gene
expression pattern (Koay et al., 2016). Due to the difficulties in
identifying them in mice, the biology and function of mouse
MAIT cells remain poorly defined, even though they have been
recognized for more than 20 years (Porcelli et al., 1993; Tilloy
et al., 1999). In the current study, we demonstrated a pivotal role
for miR-155 in the development and differentiation of mouse
MAIT cells by gain-of-function and loss-of-function studies.
We found that overexpression of miR-155 impaired MAIT cell
development, blocked MAIT cell maturation, interrupted MAIT1
and MAIT17 differentiation as well as impaired IL-17 secretion
upon activation. Whereas lack of miR-155 did not dramatically
affect MAIT cell development and function, but only impaired
thymic MAIT1 and MAIT17 differentiation.
miRNAs are non-coding RNA molecules that target hundreds
of mRNAs and influence the expression of many genes by
epigenetic regulation. In mice with a deletion of the miRNA
processing enzyme Drosha, thymic MAIT cells are primarily
arrested at stage 1, while stage 3 MAIT cells are diminished
in spleen and lymph nodes, suggesting that a complete loss
of miRNAs affects maturation of MAIT cells (Koay et al.,
2016). Deficiency of miR-181a/b impairs the development and
functional maturation of MAIT cells (Winter et al., 2019).
miR-155 is highly expressed in many hematopoietic cell types,
including B and T cells and monocytes/macrophages (Landgraf
et al., 2007), and has been identified as having multiple
roles in regulating the differentiation and responses of various
immune cells. Absence of miR-155 resulted in diminished
germinal center responses and impaired B cell memory formation
(Thai et al., 2007; Vigorito et al., 2007), failed induction
of efficient CD4+ and CD8+ T cell activation (Rodriguez
et al., 2007; Tsai et al., 2013), and reduced numbers and
diminished proliferative potential of regulatory T cells (Lu
et al., 2009). Additionally, recent studies have suggested that
miR-155 also plays a role in iNKT cell development and
function. miR-155 overexpression blocked the maturation of
thymic iNKT cells and affected thymic iNKT1, iNKT2, and
iNKT17 differentiation (Burocchi et al., 2015; Wang et al., 2021).
However, loss of miR-155 didn’t affect development of iNKT cells
(Frias et al., 2018; Wang et al., 2021).
PLZF protein regulates MAIT cell maturation (Pellicci et al.,
2020). In PLZF-null mice, stage 3 MAIT cells are completely
absent in the thymus and peripheral organs (Rahimpour et al.,
2015; Koay et al., 2016), and the PLZF-encoding gene Zbtb16 is
required for cutaneous MAIT cell development (Constantinides
et al., 2019). Approximately 70% thymic MAIT cells express
PLZF, which is consistent with the overall frequency of stage
3 MAIT cells, implying PLZF+ cells represent MAIT cells
with functional maturation (Winter et al., 2019). Thus, unlike
iNKT cells that already express substantial amounts of PLZF at
the earliest stage of development (Savage et al., 2008), MAIT
cells start to express PLZF at functional maturation stage. Our
recent study indicated that miR-155 up-regulation promotes
PLZF expression during iNKT cell development (Wang et al.,
2021). In contrast to iNKT cells, our current study showed
that overexpression of miR-155 downregulated PLZF expression
in thymic MAIT cells, suggesting a differential role in PLZF
expression by miR-155 in iNKT cells and MAIT cells. However,
miR-155 overexpression doesn’t affect PLZF expression in the
peripheral MAIT cells. How miR-155 regulates thymic PLZF
expression and MAIT cell development needs to be further
investigated in the future.
Few genes have been reported to regulate the differentiation of
MAIT cells. CCR7 is selectively required for the differentiation
of MAIT17 subset (Koay et al., 2019b), and miR-181a/b-1
downregulates expression of RORγt and T-bet only in the
thymus, but is dispensable for peripheral differentiation (Winter
et al., 2019). Here we found that overexpression of miR-155
interrupted differentiation of MAIT cells by blocking MAIT17
and promoting MAIT1 cell, which is in paralleled with our
previous result of miR-155 on iNKT cells. Overexpression of
miR-155 dramatically reduces Rictor expression (an obligatory
component of mTORC2; Laplante and Sabatini, 2009) and up-
regulation of miR-155 diminishes iNKT17 cells in thymus and
lymph nodes through targeting Rictor (Wang et al., 2021). Thus,
we suspect that, in the process of MAIT cell differentiation,
overexpression of miR-155 may repress the expression of Rictor
and block MAIT17 differentiation by the same target signaling
pathway identified in iNKT cells.
Interestingly, MAIT 17 blockage and MAIT1 promotion in
thymus were also found from miR-155 deficiency mice. So, we
proposed a hypothesis that normal expression of miR-155 is
essential to maintain the normal functional differentiation of
MAIT cells. Either overexpression or deletion of miR-155 can
modify MAIT cell differentiation by targeting different genes.
Up-regulation of miR-155 may inhibit the genes (such as Rictor)
involved in MAIT17 cells to block MAIT17 cells differentiation,
while deletion of miR-155 may increase the genes expression
involved in MAIT1 cells to promote MAIT1 cells differentiation.
Thus, adequate level of miR-155 is very important to the balance
of MAIT1 and MAIT 17 differentiation.
Unlike iNKT cells that almost all cells are CD8 negative,
four MAIT cell subsets can be identified based on expression
of CD4 and CD8. CD4+CD8−, CD4−CD8+, CD4−CD8−, and
CD4+CD8+ in the thymus, and 3 major subsets CD4+CD8−,
CD4−CD8+, CD4−CD8− MAIT cells in peripheral tissues.
CD4−CD8− MAIT cell is the majority subset in all the tissues,
but CD4+CD8− or CD4−CD8+ subsets also account for some
proportion in the thymus, spleen, LNs, and liver (Rahimpour
et al., 2015; Constantinides et al., 2019; Winter et al., 2019).
Here we examined the different subsets of MAIT cells based on
expression of CD4 and CD8 on MAIT17 and MAIT1 cells, and
found that CD4−CD8− cell subset was abundant in MAIT17
cells and the CD4−CD8+ cell subset was enriched in MAIT1
cells in the thymus, spleen, LNs, liver, and lung in WT mice.
Overexpression of miR-155 decreased CD4−CD8− subset and
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increased CD4−CD8+ subset both in MAIT1 and MAIT17
cells from thymus and peripheral organs, indicating that miR-
155 may regulate MAIT cell sub-lineage differentiation and
CD4−CD8−/CD4−CD8+ subsets.
We do realize there are some limitations in our current study,
including the dissection of miR-155 expression pattern during
thymic development (from stage 1 to stage 3) and its targeted
signaling pathways involved in MAIT cell development and
function. However, due to very limited MAIT cells we can get, so
it is very difficult to get enough thymic MAIT cells from miR-155
KI mice and miR-155KO mice to perform RNA-seq or miRNA-
seq analysis. Furthermore, given that miRNAs repress their target
genes post-transcriptionally and few protein coding genes have
been identified to regulate MAIT cell development and function
so far, it makes defining miR-155 targeting genes in MAIT
cells even harder. Finally, the cytokines production capability
(PMA/Ionomycin stimulation) detected in our study only reflects
downstream of TCR signaling pathway. TCR-dependent MAIT
cell activation, including 5-OP-RU-mediated activation, need to
be investigated in future. In conclusion, our results indicate that
adequate miR-155 expression is required for normal MAIT1 and
MAIT17 cell development and function.
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